WHAT IT IS FOR

CYSTITIS CARE is a food supplement particularly suitable for promoting the well-being of the urinary tract: ideal for both the prevention and treatment of urinary tract disorders.


FOR WHOM IT IS APPROPRIATE

    • For those who want to promote the well-being of the urinary tract (both men and women) in a natural, effective and safe way.
    • For those who want to relieve recurrent and/or occasional urinary tract disorders.
    • For women who want to prevent and protect the urinary tract from recurrent menstrual disorders.


WHAT IT CONTAINS

CYSTITIS CARE contains D-Mannose (extracted from corn), Bearberry, Cranberry, Grapefruit seed extract (GSE), Vitamin C, Bamboo.


WHY IT IS DIFFERENT FROM OTHER SUPPLEMENTS

Because, in addition to the action of D-mannose (main component), it contains the "grapefruit seed extract", which breaks down the bacterial load of pathogens present in the urinary tract.


BENEFITS OF USING CYSTITIS CARE

    1. Promotion of health and well-being of the entire urinary tract.
    2. Preventive action against recurring disorders.
    3. Stimulation of diuresis and an antioxidant effect.


SCIENTIFIC PUBLICATIONS

• "D-mannose for preventing and treating urinary tract infections". Cooper TE, Teng C, Howell M, Teixeira-Pinto A, Jaure A, Wong G.Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD013608. doi: 10.1002/14651858.CD013608.pub2.PMID: 36041061.
• "Why d-Mannose May Be as Efficient as Antibiotics in the Treatment of Acute Uncomplicated Lower Urinary Tract Infections-Preliminary Considerations and Conclusions from a Non-Interventional Study". Wagenlehner F, Lorenz H, Ewald O, Gerke P.Antibiotics (Basel). 2022 Feb 25;11(3):314. doi: 10.3390/antibiotics11030314.PMID: 35326777.
• "Systematic review of the effect of D-mannose with or without other drugs in the treatment of symptoms of urinary tract infections/cystitis (Review)". Parazzini F, Ricci E, Fedele F, Chiaffarino F, Esposito G, Cipriani S.Biomed Rep. 2022 Jun 15;17(2):69. doi: 10.3892/br.2022.1552. eCollection 2022 Aug.PMID: 3581519.
• "Pharmacodynamics of D-mannose in the prevention of recurrent urinary infections". Pani A, Valeria L, Dugnani S, Senatore M, Scaglione F.J Chemother. 2022 Nov;34(7):459-464. doi: 10.1080/1120009X.2022.2061184. Epub 2022 Apr 13.PMID: 35416116.
• "Management of recurrent cystitis in clinical practice: a nationwide survey". Ciprandi G, Aragona SE; Study Group on Urinary Infections: L. Vasciaveo, M. Cantelmi, G. Ciavolino, F. Ciarrocchi, G. Amendola, G. Micalizzi, E. Pastore, C. Salvaggio, M. Farina, R. Marino, V. Soro, F. Mastrorosa, B. Pinzello, U. Polizzotti, V. Minnella, V. Iannone.J Biol Regul Homeost Agents. 2021 Aug 27;35(4). doi: 10.23812/21-158-L. Epub 2021 Aug 6.PMID: 34355550.